A new vaccine against pneumococcal disease appears as safe as an older one, according to a new study.
A Virginia-based pharmacy school will collaborate with an alliance of more than 22,000 pharmacies around the country to find ways to promote and increase pneumococcal vaccinations among elderly and high-risk people.
The Food and Drug Administration has approved a new use for a pneumococcal vaccine made by Pfizer, the drug maker said.
The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has updated its recommendations for pneumococcal vaccine in high-risk adults.
The Food and Drug Administration has approved a Pfizer vaccine for Streptococcus pneumoniae in adults ages 50 years and older, the company said.
A phase-3 clinical trial found that a pneumococcal disease vaccine was well-tolerated and immunogenic in...
The Food and Drug Administration has approved a vaccine for preventing pneumococcal disease in children,...